The primary pathophysiological events contributing to fatal malaria are the cerebral syndrome, anemia, and lactic acidosis. The molecular basis of each event has been unclear. In the present study, microarray analysis of murine transcriptional responses during the development of severe disease revealed temporal, organ-specific, and pathway-specific patterns. More than 400 genes in the brain and 600 genes in the spleen displayed transcriptional changes. Dominant patterns revealed strongly suppressed erythropoiesis, starting early during infection, and highly up-regulated transcription of genes that control host glycolysis, including lactate dehydrogenase. The latter presents a mechanism that may contribute to metabolic acidosis. No evidence for hypoxia-mediated regulation of these events was observed. Interferon-regulated gene transcripts dominated the inflammatory response to cytokines. These results demonstrate previously unknown transcriptionalchanges in the host that may underlie the development of malarial syndromes, such as anemia and metabolic dysregulation, and increase the utility of murine models in investigation of basic malarial pathogenesis.
dromes are poorly understood. Murine models of severe malaria manifest a range of organ-specific and systemic disease syndromes that correspond, to a reasonable degree, to these human disease processes [1] [2] [3] . Depending on genetic influences, both mice and humans can also develop cytokine-associated encephalopathy-with up-regulation of adhesins on the cerebral microvascular endothelium, sequestered parasites [4] , and infiltrating leukocytes [5] [6] [7] -and attendant neurological complications [8] [9] [10] [11] .
Time-course analysis of the host transcriptional response to infection can provide novel insights into the causes of fatal pathogenesis, particularly when the coregulated expression of genes implicates activation or repression of key regulatory pathways. Transcriptional analysis might also clarify areas of similarity and difference between humans and animal models, thereby refining the utility of the latter. Therefore, to investigate proximal processes during development of severe murine malaria, we applied microarray analysis of 15,000 mouse probe sets, representing 6000 functionally characterized sequences, plus 6000 expressed sequence tag 1 ϫ 10 confirmed to be free of Mycoplasma species and adventitious viral agents. A minimum of 2 mice were used for every measurement at each time point. Uninfected mice were included as controls. Microarrays comparing uninfected mice with mice injected with uninfected red blood cells (RBC) showed negligible differences after 5 days. At days 1, 3, and 5 after infection, before the onset of detectable symptoms, parasitemia and levels of reticulocyte were assessed by use of microscopy (Giemsa stain), and organs were extracted and immediately placed in RNAlater (Qiagen). Duplicate infections were undertaken for measurements of splenomegaly and lung edema, histologic examination, and extraction of RNA from bone marrow. For histological analysis of cerebral pathologic lesions, brains were placed in 10% neutral-buffered formalin, sectioned (5 mm), and stained with hemotoxylin-eosin. Bone marrow was Giemsa-stained. Splenocytes were released by mechanical disruption, resuspended in RBC lysis buffer on ice, washed, and counted by use of a hemocytometer (Neubauer). Lung edema was expressed as the ratio of wet weight (immediately after removal of the organ) to dry weight (determined after incubation at 80ЊC for 72 h).
Microarray analyses. For microarray hybridization and analysis, all cDNA and RNA synthesis reactions were performed according to the Affymetrix Gene Chip Expression Analysis technical manual, and Affymetrix murine U74v2 arrays were used. Analyses were conducted by use of GenesSpring software (Silicon Genetics), after importing signal measurements from Microarray Suite 5.0 (MAS5.0; Affymetrix). The data from 1 spleen sample from day 1 indicated a lower hybridization quality, so the sample was omitted from subsequent analyses. For normalizations, the 50th percentile of all measurements was used as a positive control for each sample; each measurement for each gene was divided by this synthetic positive control, assuming that this was at least 10. The bottom 10th percentile was used as a test for correct background subtraction. This was never less than the negative of the synthetic positive control. The measurement for each gene in each sample was divided by the corresponding value at day 0 (average of 2 samples), assuming that it was at least 0.01, to obtain the final normalized value for each probe set (gene). An individual probe set was said to have changed only if the ratio was 12.0 or !0.5 in both samples at that time point. Measurements for which the signal was deemed to be absent by use of MAS5.0 analysis were excluded. Normalized data were later grouped according to fold change and biological pathway or molecular function, by use of GenMAPP software (version 1.0; J. David Gladstone Institute).
Real-time PCR. Real-time PCR analyses were performed by use of a Roche Lightcycler using Quantitect SYBR Green PCR master mix (Qiagen). Standard curves were generated, and quantities of each transcript were compared to a b-actin reference. Amplification primers were 5 -CTGGGGAAGACAAAAGCAA-CATC-3 and 5 -GCGACCTTCTTGCCGTGAC-3 for globin-a, and 5 -CTTGGACAGTGATTTGGAGAC-3 and 5 -AGTACCC-ATTAGCCAAACAG-3 for interferon-inducible GTPase (IIGP). Primers for tumor necrosis factor (TNF)-a, b-actin, interferon (IFN)-g, and LT-a were as described elsewhere [12] [13] [14] .
RESULTS
Reproducible patterns of transcriptional change during infection revealed by microarrays. We used the Affymetrix mouse U74Av2 array, which includes 15,000 probe sets that represent functionally characterized sequences (6000) in the mouse UniGene database plus 6000 EST clusters. Analysis of the gene transcripts revealed distinct and highly reproducible changes (12-fold increase or decrease, relative to uninfected controls) at each time point (figure 1). The intensity data for detectable transcripts from duplicate mice were strongly correlated (spleen: day 0, ; day 1, ; day R p 0.972 R p 0.967 R p 0.988 was an early transcriptional response (day 1) that was distinct from later changes (day 5) and was particularly evident in the brain ( figure 1 ). Changes at day 3 appeared intermediately; often, transcripts that were increased or decreased at day 1 still showed a 12-fold change in expression at day 3, and other transcripts that began increasing by day 3 were still elevated at day 5 ( figure 1A ). When we counted gene tags with 12-fold expression changes, in both mice for each time point, in brains, at day one, 99 were up-regulated and 266 were down-regulated; at day three, 29 were up-regulated and 17 were down-regulated; and, at day five, 90 were up-regulated and 22 were downregulated. In spleens, at day one, 35 gene tags were up-regulated and 42 were down-regulated; at day three, 81 were up-regulated and 39 were down-regulated; and, at day five, 529 were upregulated and 71 were down-regulated (figure 1B). Table 1 provides the names and details of categories of probe sets that changed in the spleen. Interestingly, these constitute only a Figure 1 . Overall results of microarray analyses of brains and spleens. A, Overall pattern of genes with changing transcript levels in brains (left panels) and spleens (right panels) of infected C57BL/6 mice, compared with uninfected mice (day 0). Fold change is on the Y-axis and is plotted against time point (days 0, 1, 3, and 5) on the X-axis. Blue lines, transcripts increasing (top panels) or decreasing (lower panels) on day 1 only; green lines, changes on day 3 only; red lines, changes on day 5 only; aqua lines, genes that changed on day 1 and day 3; yellow lines, genes that changed on day 3 and day 5; purple lines, genes that changed on day 1 and day 5; and white lines, genes that changed on all 3 days. B, Venn diagrams showing nos. of transcripts that increased and decreased, respectively, at each time point in brains and spleens. Color scheme is as above, except that genes that changed at all 3 days are in black instead of white.
small percentage of the genes represented on the chip, suggesting a specific and directed response to malaria infection (figure 1B).
Histopathologic examination of spleens, lungs, and brains. Although macrophage occlusion of cerebral vasculature becomes evident by days 6-7 of infection in the mouse and can be associated with fatal cerebral malaria in both mice and humans [5] [6] [7] , histologic examinations of brains performed throughout these experimental infections showed no evidence of infiltrates at day 1, 3, or 5. Furthermore, spleen mass and cellularity remained substantially unchanged over the early time course (8.7 ϫ 10 7 ‫ע‬ 0.3 ϫ 10 7 splenocytes in uninfected mice vs. 1.08 ‫ע‬ 0.04 ϫ 10 8 splenocytes in infected mice on day 1; 1.37 ϫ 10 8 ‫ע‬ 0.02 ϫ 10 8 splenocytes in infected mice on day 3; and 1.11 ‫ע‬ 0.2 ϫ 10 8 splenocytes in infected mice on day 5). Lung edema increased slightly by day 5 (wet:dry weight ratio, 5.65 ‫ע‬ 0.45 in infected mice vs. 5.07 ‫ע‬ 0.13 in uninfected mice). Hence, although a contribution by cellular infiltrates cannot be completely excluded, the transcriptional changes seen here are unlikely predominantly to reflect influx or efflux of migratory cells. Because cerebral infiltrates, coagulopathy, lactic acidosis, pulmonary edema, and splenomegaly are not usually observed until later in infection, these results are consistent with those of previous studies [15, 16] and support an analysis of early time points before the onset of frank pathologic abnormalities.
Increased transcription of genes of the glycolysis pathway. Microarray analysis proved to be informative in revealing the transcriptional regulation of several important biological pathways in response to infection. Of note, genes for 9 of the 11 steps of the ubiquitously expressed glycolysis pathway were transcriptionally up-regulated in the spleen by day 5 (figure 2). This did not occur in the brain. The induction of the glycolytic pathway is a novel finding and indicates an increase in the production of lactate, because the up-regulated lactate dehydrogenase isoform (LdhA) favors the conversion of pyruvate to lactate. Furthermore, expression of genes involved in the tricarboxylic acid (TCA) cycle did not change, and pyruvate dehydrogenase kinase, an inhibitor of pyruvate dehydrogenase, was up-regulated, effectively diverting pyruvate to conversion to lactate by LdhA ( figure 2) . Similarly, transcripts of bisphos- phoglycerate mutase, which shunts products out of the glycolytic pathway, decreased by 8-fold.
Lactate accumulation and associated metabolic acidosis occur both in this rodent model [15, 16] and in human malaria [17] . In humans, lactic acidosis is the strongest prognostic indicator of poor outcome and is thought to be a primary pathophysiological process in fatal disease [18] . In the P. bergheiinfected mouse model, detectable changes in blood lactate levels usually occur after day 7 of infection in mice that have survived the window of susceptibility to cerebral malaria. However, there are some studies of P. berghei-infected C57BL/6 mice in which increases in serum lactate levels have been found after day 4 [15] or day 6 [16] . In the present study, significant increases in blood lactate levels were not detected at day 1, 3, or 5, which were chosen as proximal time points for transcriptional analysis before the onset of severe symptoms (data not shown). Increased host glycolysis is proposed to contribute significantly to blood lactate levels in malaria [18] , but experimental evidence has been lacking. Hypoxia is a potent transcriptional regulator of anaerobic glycolysis, and it has been proposed that, in malaria, hypoxia develops secondary to anemia, vascular obstruction by sequestered parasites, or impaired circulatory perfusion [18] . Hypoxia induces transcription of diverse pathways acting at intracellular, extracellular, and systemic levels, including glucose transporters, hypoxia-inducible factor (HIF1a), HIF-1a-related factor, c-fos, c-jun, inhibitor of apoptosis 2, vascular endothelial growth factor-B, prolyl 4-hydroxylase (P4ha), and tyrosine hydroxylase (produced in the brain). Surprisingly, however, most of these hypoxia-inducible elements were among the thousands of genes that, although they yielded detectable transcripts, failed to fluctuate in the early stages of malaria infection. Moreover, the changes that did occur were the opposite of the changes that were predicted: at day 5, levels of c-fos were decreased by 3-4-fold in the brain, levels of P4ha were decreased, and levels of hypoxia-inducible Nix were decreased in the spleen. Levels of cytokine-inducible Mrg-1/CITED2, a potent counter-regulator of hypoxia, were increased. Glycolytic flux is regulated only in part by gene expression; therefore, failure to detect hypoxic responses does not exclude a contribution by hypoxia to malarial pathogenesis. Nonetheless, it seems unlikely that the increased transcription of the glycolytic enzyme genes observed here results from hypoxia secondary to anemia or reduced circulatory perfusion, especially given the early time points under consideration. It is conceivable that independent pathways converge with hypoxia contributing to yet higher levels of anaerobic glycolysis at later time points.
Evidence for suppressed erythropoietic transcription contributing to malarial anemia. Anemia is the most serious pernicious complication of malaria and probably causes the majority of malarial deaths worldwide [19] . The molecular basis of anemia remains obscure, but it is thought to reflect both increased destruction of and decreased production of RBCs. In humans, levels of reticulocytes may be abnormally low during P. falciparum infection, and this is alleviated by treatment with antimalarial drugs. Active erythropoietic suppression by an unknown mechanism is thereby inferred. Malarial anemia is relatively under-studied in animal models, because their excessive parasite burdens induce a massive hemolytic anemia of uncertain physiological relevance. In the present study, parasitemia was virtually undetectable at day 1, was 2% at day 3, and was 18% at day 5 ( figure 3A) . A sharp (10-fold) decrease in total levels of reticulocytes early during infection was observed. This was not the result of parasitization of reticulocytes by P. berghei, which prefers normocytes until later time points, be- cause this was accounted for by careful differential microscopic analysis. Although erythropoiesis should increase to compensate for galloping destruction of RBCs, we observed an initial repression of erythroid-associated transcripts (table 1) as early as day 1 in the spleen, a primary erythropoietic site. These include transcripts for erythroid transcription factor (EKLF), NFE2 (a required transcription factor in erythroid differentiation), the heme biosynthetic pathway enzyme d-aminolevulinate dehydratase, glycophorin A, aquaporin-1, and erythrocyte membrane proteins Rh50 and Rh30. Erythroid carbonic anhydrase II transcripts decreased throughout days 1, 3, and 5. By day 5, transcription of many erythroid-specific or -associated genes had clearly decreased in the spleen, most notably the hemoglobin-a and -b subunits, erythroid ankyrin, and genes encoding heme biosynthetic enzymes. Some genes, such as DAF, although not exclusive to RBCs, are strongly expressed in the erythroid lineage, and levels of these were also reduced. Transcripts of cytokines SDF-1a and SDF-1b, which play a role in erythroid and hematopoietic development, were also downregulated. As applied to down-regulated transcripts, our conservative analysis includes only those flagged as present in both uninfected and infected mice on the day in question. Extension of analysis to include transcripts present in both control mice but deemed to be absent from both test mice revealed the disappearance of transcripts for additional erythroid-associated genes, including Uros3, Car-1, erythrocyte membrane protein band 3, 5 aminolevulinic acid synthase, and the erythroblastoid growth regulator Gfi-1B. Reduction in hemoglobin gene globina transcripts in the spleen was confirmed by use of quantitative PCR ( figure 3B) .
Transcripts of globin-a, along with other genes regulating erythropoiesis and erythroid cell survival-such as GATA-1, Bcl-x, and EKLF-also decreased in bone marrow ( figure 3C ). Histologic analysis of bone marrow revealed the presence of modest levels of parasitized erythrocytes, but no abnormal or gross pathologic lesions (data not shown). These data therefore establish molecular evidence for significant ongoing erythropoietic suppression in the 2 primary sites of RBC production, commencing at the earliest times during malaria infection (day 1), preceding and subsequently associated with reduced levels of peripheral reticulocytes, and in the face of significant parasite-induced hemolysis. Levels of erythropoietin in murine and human malarial anemia appear to be physiologically appropriate [19] , suggesting a functional lesion at or downstream of the erythropoietin receptor. Our data establish broadly based suppression, involving reduced expression of up to 25 loci, including diverse essential transcription factors and growth factors at the earliest point of erythroblastogenesis, downstream biosynthetic pathways, and structural/functional products.
Cytokine and chemokine genes. Considerable transcriptional regulation of chemokines and their receptors was apparent. Transcripts of IP-10 (CXCL10), an IFN-g-inducible Th1 chemokine that attracts T lymphocytes and NK cells through activation of Th1-associated CXCR3, were increased in brains and spleens, as were transcripts of IFN-g-induced monokine, which binds the same receptor. Transcripts of CXCR3 itself and of 2 other chemokine receptors, CCR5 and CCR1, increased in spleens by day 5. Expression of CCR5 (Cmkbr5) and CXCR3 are strongly associated with Th1 responses. Splenic transcripts of JE cytokine MCP-1 (CCL2) increased by day 3, and splenic transcripts of macrophage inflammatory protein (MIP)-1g (MIP1-g) and MIP-1a (CCL3) increased by day 5, whereas splenic transcripts of TCA4 (CCL21) were decreased (table 1) .
Cytokines are believed to play significant roles in promoting or counter-regulating malarial pathogenesis. Our results show that suppressor of cytokine signalling-2 (SOCS-2) began to increase by day 3 and that SOCS-1, -2, and -3 were all upregulated in spleens by day 5, suggesting the activation of a negative-feedback loop. Although transcriptional responses of other genes to cytokines were observed (discussed below), cytokine transcripts were negligible or undetectable in this microarray analysis. Quantitative PCR analysis showed very low, unchanging levels of LT-a (data not shown) and a slight (1.5-fold) increase in TNF-a transcripts in spleens by day 3, but levels remained below detection limits in brains. IFN-g, however, was induced several fold by days 3 and 5, in both brains (data not shown) and spleens ( figure 4A) .
Increased transcript levels of IFN-inducible genes. Consistent with detection of increased IFN-g mRNA, many IFNinducible gene transcripts strongly increased in brains and spleens. Among families of such genes were those encoding the proteasome (10 genes and 1 homologous EST up-regulated in the spleen by day 5), several IFN-regulatory factors (transcription factors)-including IFN regulatory factor (Irf7 and mirf7), Stat1, lymphoid-specific interferon regulatory factor (LSIRF)-and 2 families of IFN-g-induced GTPases thought to be important in defense against intracellular pathogens [20, 21] . All 6 known members of the 47-kDa family-IIGP, IFN-g-inducible proteins (IRG-47 and LRG-47), IFN-g-induced GPTase (IGTP), T cell-specific GTPase (TGTP) (Mg21), and GTPIwere induced 15-fold by day 5 in the brain ( figure 4B ). Expression changes for 1 of these genes, GTPase IIGP, was confirmed by real-time quantitative PCR, and the results closely matched the quantitative array data for brains ( figure 4C ) and spleens (data not shown). Major histocompatibility complex (MHC) class I genes, which were markedly increased in the brain and spleen, are IFN-g inducible [22] . Glucocorticoid attenuated response genes GARG-16, -39, and -49, which are inducible by IFN-g and microbial products [23] , increased in brains and spleens by day 5 of infection. IFN-g is implicated in suppression of hematopoiesis [24, 25] , and may therefore contribute to the repressed transcription of erythroid genes observed here. However in the case of glycolytic enzymes, to date, there is little evidence for significant transcriptional or posttranslational regulation by cytokines.
Our data point to a central role for IFN in regulating downstream transcription of a significant number of loci, a result that is consistent with those of previous studies showing a requirement for IFN-g in murine cerebral malaria [8] . Plasma TNF-a levels are clearly associated with severe disease in humans [26] , but association of disease with IFNs is less established. Although it is possible that the mouse model diverges from human disease in this respect, closer investigation of the associations of human malarial disease with bioactivity and genetics of IFNs may prove to be informative.
Other trends in gene expression. In humans, shock-associated syndromes, such as disseminated intravascular coagulation (algid malaria), can occur, but less frequently than other complications. In C57Bl/6 mice, fatality at day 7 is more often associated with coagulopathy. A number of genes involved in regulation of coagulation-including serum amyloid A, thrombospondin, and thrombomodulin-were differentially transcribed during infection (table 1). The endothelial cell protein C receptor, which augments the activation of protein C by the thrombin-thrombomodulin complex, showed increased transcription. Repair of the extracellular matrix was evident from increased splenic transcription of collagen genes-including Mmp1, Col1a1, Col1a2, Col3a1, Col4a1, and Col5a1, and the collagen-specific chaperone hsp47 (table 1)-which is in marked contrast to bacterial sepsis, where splenic collagen gene transcription is repressed at early time points [27] .
As expected, transcription of many innate or acquired immune systems genes was differentially regulated, including loci previously implicated in the regulation of malarial pathogenesis or immunity in mice and humans. Immunoglobulins were upregulated in brains and spleens (except IgA, which was downregulated). One or more genes encoded within a 2-centimorgan interval in the natural killer complex (NKC) have recently been shown critically to regulate the IFN-g cascade and fatal pathogenesis in this P. berghei ANKA model [28] , and transcription of 7 NKC receptors was increased early in infection in either brains or spleens, including several Ly-49 alleles and the inducible human killer inhibitory receptor homologues gp49A and gp49B. Transcripts of genes encoding the cytotoxicity proteases granzymes A and B were induced in brains and spleens by day 5. IkBa transcripts increased during infection, which is consistent with the primary role of NF-kB in transcriptional regulation of acute-phase and stress responses. Cellular adhesion molecules vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 (ICAM-1), which are targets of parasite and leukocyte adhesion implicated in human and murine cerebral malaria pathogenesis, increased transcription by day 5. Ctla-4, which is involved in the extensive T cell anergy observed during malarial infection [29, 30] , was up-regulated in the spleen (table 1) .
DISCUSSION
It has been proposed that transcriptional profiles might reveal pathogen-specific "fingerprints" [31] . However, as yet, there have been very few studies using microarrrays for in vivo transcriptional analysis of pathogenic disease. One such study was of bacterial sepsis [27] , which has been likened to severe malaria in that both conditions are associated with an exacerbated systemic inflammation. However, the organ-specific transcriptional response to bacterial sepsis differs significantly from the profiles elucidated here. Unlike in malaria, in sepsis, the brain appears to be minimally perturbed [27] . Microarray analysis of sepsis reveals no evidence of the altered splenic transcription of glycolytic, erythropoietic, or MHC class I genes that we observed during malaria. Furthermore, sepsis, unlike malaria, elicits much greater flux in cytokine transcripts, increased transcription of the complement system, and repression of collagen [27] . In contrast, several up-regulated transcripts detected in our in vivo analysis were also elicited by other intracellular protozoal pathogens in highly defined, monotypic nucleated cell lines. For example, strong expression of IFN-g-inducible genes was the clearest response in Trypanosoma cruzi-infected human fibroblasts [32] . IkBa and ICAM-1 increased in a human fibroblast cell line in response to Toxoplasma gondii infection. Likewise STAT1 is induced in cultured human cell lines infected with T. gondii or T. cruzi [32, 33] and in the in vivo P. berghei infections described here. A very similar pattern of expression of genes encoding glycolytic enzymes was observed in T. gondii infection of a human fibroblast cell line [33] ; as we observed in the in vivo malaria model, LdhA was up-regulated, and glucose-6-phosphate isomerase was one of the few glycolytic genes for which expression did not change (figure 2). Since these changes are observed in monotypic cell lines, it seems that exogenous factors, such as hypoxia and T cellderived IFN-g, are not necessarily required for transcriptional regulation of these pathways. It is possible that these common transcriptional events are a feature of generalized pattern-recognition responses to protozoal pathogens and their products.
Of ∼30,000 mouse genes, 99% have homologues in humans [34] . We observed only a small minority fluctuating transcriptionally in response to malarial insult. Identification of the most important genes of the mouse that influence susceptibility and resistance to malaria could speed identification of parallel genes in humans. Although there are limitations in the transcriptome approach, in that no quantitative relationship between mRNA levels and function is guaranteed, we, nonetheless, have newly established clear pathways and patterns in gene expression that may contribute to severe malaria syndromes, such as metabolic acidosis, anemia, and the inflammatory cascade. Although erythropoietic suppression is accepted as contributing to malarial anemia [35] , molecular evidence for the control of this process has been lacking, especially at a transcriptional level. Similarly, although it has been hypothesized that increased glycolysis, whether of parasite or host origin, could be a factor in the development of lactic acidosis, we provide evidence that increased host glycolysis may play a major role. In addition, we have identified hundreds of other genes that respond to malarial infection, providing a greatly expanded framework for further investigations and comparisons with other diseases. Transcriptional profiling may therefore prove to be useful in elucidating causal relationships in pathogenesis and immunity, particularly when used in conjunction with targeted gene deletion and congenic mice, and should enable the similarities and differences of experimental models to be more clearly compared with clinical material from humans. Generation of appropriate clinical samples and extension into other rodent malarias will be important future steps in comparison of malarial pathogenesis across host and parasite taxa. Microarray technology therefore extends the utility of rodent malarias as models for infection in humans.
